Melior Pharmaceuticals partnering with us

Melior seeks to co-develop our portfolio compounds with partners who can provide the scientific and financial resources to optimize market potential. We develop our compounds to clinical proof-of-concept and then seek partners to complete drug development and bring the compound to market.

To discuss collaborative opportunities with Melior, please contact:

Dr. Andrew Reaume
President & CEO
(610) 280-0633  ext. 239
bizdev@meliordiscovery.com